期刊文献+

黄芪注射液联合50%葡萄糖注射液治疗尿毒症合并慢性心功能不全患者透析相关性低血压临床观察 被引量:7

Astragalus Combined with 50%Glucose in Treatment of Patients with Uremia Combined with Chronic Cardiac Insufficiency Hypotension Correlation by Dialysis
下载PDF
导出
摘要 目的探讨黄芪注射液联合50%葡萄糖注射液治疗尿毒症合并慢性心功能不全患者透析相关性低血压的临床疗效。方法选择2009年1月—2010年12月在我院透析过程中反复发生低血压的尿毒症合并慢性心功能不全的患者40例,将其随机分成2组,每组20例,对照组常规血液透析过程中加50%葡萄糖注射液持续静脉滴注,观察组在对照组基础上加用黄芪注射液,治疗8周,观察两组血压变化情况及治疗效果。结果治疗过程中低血压发生率观察组低于对照组(P<0.05);治疗后观察组收缩压、平均动脉压均高于对照组(P<0.05,P<0.01);两组治疗后左心室射血分数(LVEF)均高于治疗前,且治疗后LVEF观察组高于对照组(P<0.05);治疗总有效率观察组高于对照组(P<0.05)。结论黄芪注射液联合50%葡萄糖注射液可降低尿毒症合并慢性心功能不全患者透析相关性低血压发生率,明显地增加了LVEF,提高了对透析的耐受性。 Objective To explore the clinical effect of astragalus injection combined with 50% glucose in treatment of patients with uremia combined with chronic cardiac insufficiency hypotension correlation by dialysis.Methods 40 patients with uremia combined with chronic cardiac insufficiency who had repeatedly dialysis related hypotension in hemodialysis during January 2009 and December 2010 were randomly divided into therapy group(n=20) and control group(n=20).Patients in control group were treated with 50% glucose injection,while therapy group were treated with 20ml astragalus combined with 50% glucose by continuous intravenous infusion.The changes of blood pressure and treatment effectiveness of the two groups were compared.Results The incidence of hypotension therapy group was lower than that of control group during course of treatment(P0.05);systolic blood pressure and mean arterial blood pressure of therapy group were higher than those of control group after treatment(P0.05,P0.01);LVEF was higher after treatment than that before treatment in two groups,and LVEF increment in therapy group after treatment was higher than that of control group(P0.05);the total effective rate of treatment in therapy group was higher than that of control group(P0.05).Conclusion Astragalus injection combined with 50% glucose in treatment of patients with uremia combined with chronic cardiac insufficiency hypotension correlation by dialysis can reduce incidence rate,significantly improve LVEF and raise dialyzed tolerance.
作者 高丽华 孙宇
机构地区 解放军
出处 《解放军医药杂志》 CAS 2012年第10期46-49,共4页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
关键词 黄芪 葡萄糖 血液透析滤过 低血压 Astragalus membranaceus Glucose Hemodiafiltration Hypotension
  • 相关文献

参考文献22

  • 1黄赞维,冯小兰.老年患者血液透析相关性低血压发生原因分析及防治[J].现代医药卫生,2010,26(9):1380-1381. 被引量:3
  • 2胡晓玲,解德琼,吴雅琳,张欣欣.可调钠联合超滤曲线对糖尿病肾病血液透析中低血压的预防[J].四川医学,2011,32(2):220-222. 被引量:7
  • 3Montagnac R, Clavel P, Delhotal Landes B, et al. Use of midodrine (Gutron) to treat permanent hypotension in a chronic hemodialysis patient[ J ]. Clin Nephrol, 2001,56 (2) :162-168.
  • 4Flynn J J, Mitchell M C, Caruso F S, et al. Midodrine treatment for patients with hemodialysis hypotcnsion [ J ]. Clin Nephrol, 1996,45 ( 4 ) :261-267.
  • 5Sarnak M J, Levey A S. Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease [ J ]. J Thromb Thrombolysis, 2000,10 ( 2 ) : 169-180.
  • 6Selby N M, Lambie S H, Camici P G, et al. Occurrence of regional left ventricular dysfunction in patients undergo- ing standard and biofeedback dialysis [ J]. Am J Kidney Dis, 2006,47 ( 5 ) : 830-841.
  • 7Harnett J D, Foley R N, Kent G M, et al. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors [ J ]. Kidney Int, 1995,47 ( 3 ) : 884-890.
  • 8张兰,程明,俞琦,朱晓峰,吴婷婷,楼柏杨,陈佳敏.低温透析对透析中低血压患者左心室功能的影响[J].中国血液净化,2008,7(10):538-541. 被引量:11
  • 9Wijns W, Vatner S F, Camici P G. Hibernating myocar- dium[J].N Engl J Med, 1998,339(3) :173-181.
  • 10Smith M D, MacPhail B, Harrison M R, et al. Valueand limitations of transesophageal echocardiography in de- termination of left ventricular volumes and ejection frac- tion[J]. J Am Coil Cardiol, 1992,19(6):1213-1222.

二级参考文献113

共引文献391

同被引文献99

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部